INCYTE CORP (INCY): SEC Filings & AI Analysis
Health Care. Latest 10-K, 10-Q, and 8-K filings for INCYTE CORP (INCY) with AI risk scoring and cited answers, grounded in primary-source SEC EDGAR data.
Most recent filing — 8-K filed November 13, 2026: NEUTRAL Concern level: ELEVATED.
Company overview — key questions
Answers are generated from SEC filings and StockHuntr's analysis. Not investment advice.
What is INCYTE CORP (INCY)?
INCYTE CORP is a publicly traded company in the Health Care space tracked on StockHuntr, which analyzes its SEC filings (10-K, 10-Q, 8-K) and generates 30-day stock predictions.
What are INCY's most recent SEC filings?
Recent filings: 8-K (November 13, 2026), 8-K (October 29, 2026), 10-Q (October 29, 2026), 8-K (August 31, 2026), 8-K (July 28, 2026).
What does INCY's latest filing analysis show?
INCY's most recent 8-K (November 13, 2026) is rated NEUTRAL, concern level ELEVATED.
Is INCY a buy?
StockHuntr doesn't issue buy or sell ratings — it's a research tool. For INCYTE CORP (INCY), its latest 8-K is rated ELEVATED concern. Weigh these filing-based signals alongside your own research. This is model analysis for research, not investment advice.
Recent INCY filings analyzed
- 8-K · Nov 13, 2026 · concern 4.2/10
- 8-K · Oct 29, 2026 · concern 5.2/10
- 10-Q · Oct 29, 2026 · concern 5.2/10
- 8-K · Aug 31, 2026 · concern 3.8/10
- 8-K · Jul 28, 2026 · concern 6.2/10
Compare across the sector: Health Care sector analysis →
Other Health Care companies
About this analysis
- Primary source:
- View this company's filings on SEC EDGAR
- Additional data:
- Yahoo Finance (market data)
- Method:
- StockHuntr analyzes filings with AI — see our methodology.
- Analysis as of:
- November 13, 2026
- Published by:
- StockHuntr
For research and education only. Nothing here is investment advice.
Loading INCY snapshot...
Fetching live market data